Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
5.67
+0.13 (2.35%)
At close: Feb 21, 2025, 4:00 PM
5.77
+0.10 (1.76%)
After-hours: Feb 21, 2025, 5:20 PM EST

Phathom Pharmaceuticals Market Cap

Phathom Pharmaceuticals has a market cap or net worth of $387.70 million as of February 21, 2025. Its market cap has decreased by -4.35% in one year.

Market Cap
387.70M
Enterprise Value
572.01M
1-Year Change
-4.35%
Ranking
Category
Stock Price
$5.67

Market Cap Chart

Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $527.13M to $387.70M, a decrease of -26.45%. That is a compound annual growth rate of -5.60%.

History

DateMarket Cap% Change
Feb 21, 2025387.70M-30.17%
Dec 31, 2024555.22M6.22%
Dec 29, 2023522.72M13.23%
Dec 30, 2022461.63M-22.48%
Dec 31, 2021595.53M-36.35%
Dec 31, 2020935.68M22.51%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 782.55B
UnitedHealth Group 461.93B
Johnson & Johnson 384.35B
Novo Nordisk 370.06B
AbbVie 354.33B
Abbott Laboratories 230.73B
AstraZeneca 227.07B
Merck & Co. 221.29B
Market Cap Rankings